Allergy Asthma
Clinical tool demonstrates validity in assessments for COPD, asthma, type 2 diabetes
A recent study in Annals of Family Medicine confirmed the validity and reliability of a clinical tool in assessing burdens of COPD, type 2 diabetes and asthma.
Familiarity with oral immunotherapy for food allergy varies by race, ethnicity
LOUISVILLE, Ky. — Familiarity with oral immunotherapy as treatment for food allergy significantly varies by race and ethnicity, according to a presentation at the American College of Allergy, Asthma & Immunology Annual Scientific Meeting.
Omalizumab may help treat idiopathic anaphylaxis in patients who failed on prior therapies
Omalizumab may effectively treat idiopathic anaphylaxis in patients without indication of mast cell clonality and who have failed on prior treatments, according to study results published in Annals of Allergy, Asthma & Immunology.
Incoming ACAAI president discusses goals, highlights from annual meeting
Luz Fonacier, MD, professor at NYU Long Island School of Medicine, will be installed as president of the American College of Allergy, Asthma and Immunology on Saturday, Nov. 14, during the organization’s annual scientific meeting, held virtually from Nov. 13 to 15.
Allergy-related ED visits rising; four ways PCPs can help reverse trend
Allergy-related ED visits increased 14% in the United States between 2007 and 2015, researchers wrote in The Journal of Allergy and Clinical Immunology: In Practice.